ExpandAt 15 months post-treatment, 12.5% of bariatric surgery patients had a new diagnosis of nutritional or iron-deficiency anemia, compared to 4.6% of GLP-1 patients and 3.8% of patients on other weight-loss medications.
ExpandAt 15 months post-treatment, 12.5% of bariatric surgery patients had a new diagnosis of nutritional or iron-deficiency anemia, compared to 4.6% of GLP-1 patients and 3.8% of patients on other weight-loss medications.
ExpandThe share of outpatient encounters with a systemic antibiotic prescription fell from 10.4% pre-pandemic to 8.0% during the pandemic and partially returned to pre-pandemic levels at 9.1% post-pandemic.
ExpandThree months after stopping a GLP-1, 40% of patients had further improved their HbA1c compared to when they discontinued the GLP-1, 48% kept some of their improvement, and just 12% had a worse HbA1c compared to their pre-GLP-1 level.
ExpandScarlet fever diagnoses among pediatric patients dropped sharply during the COVID-19 pandemic and then surged well above pre-pandemic levels, peaking around 47 per 100,000 pediatric patients who had a visit in Q1 2023 and Q1 2024, nearly double the pre-pandemic seasonal peak of 24 per 100,000 in Q1 2019. By Q1 2025, the peak was down to 18.9 per 100,000.
ExpandScarlet fever diagnoses among pediatric patients dropped sharply during the COVID-19 pandemic and then surged well above pre-pandemic levels, peaking around 47 per 100,000 pediatric patients who had a visit in Q1 2023 and Q1 2024, nearly double the pre-pandemic seasonal peak of 24 per 100,000 in Q1 2019. By Q1 2025, the peak was down to 18.9 per 100,000.
ExpandTwo new data trackers from Epic Research now provide quarterly snapshots of GLP-1 use and BMI distribution in the U.S. adult population.
ExpandTwo new data trackers from Epic Research now provide quarterly snapshots of GLP-1 use and BMI distribution in the U.S. adult population.
ExpandMost patients who lost weight before hip or knee replacement had a higher likelihood of surgical site infection and mechanical failure than patients in the same starting BMI class whose weight remained stable. For infection, the likelihood increased with each level of loss, reaching more than six times as likely among overweight patients who lost 20% or more before knee replacement.
ExpandMost patients who lost weight before hip or knee replacement had a higher likelihood of surgical site infection and mechanical failure than patients in the same starting BMI class whose weight remained stable. For infection, the likelihood increased with each level of loss, reaching more than six times as likely among overweight patients who lost 20% or more before knee replacement.
ExpandPatients who received a short-term opioid prescription within seven days of a hip replacement surgery had a slightly higher proportion of top-tier functional scores at three months (69.8%) compared to those who did not receive opioids (59.3%).
ExpandPatients who received a short-term opioid prescription within seven days of a hip replacement surgery had a slightly higher proportion of top-tier functional scores at three months (69.8%) compared to those who did not receive opioids (59.3%).
ExpandMale patients aged 10 to 15 who had an ED visit for a motor vehicle crash (MVC) were as much as four times as likely to experience a subsequent firearm injury compared with those whose ED visit was for a fall, in some parts of the United States.
ExpandThe risks of myocardial infarction (MI), ischemic stroke, and hemorrhagic stroke are increased for patients with high or low average systolic blood pressure (BP). The risks are greater at very low systolic BP than at very high systolic BP.
ExpandAt 24 months post-cessation, 56% of semaglutide, 52% of liraglutide, and 55% of tirzepatide patients kept the weight off or lost additional weight.
ExpandMale patients aged 10 to 15 who had an ED visit for a motor vehicle crash (MVC) were as much as four times as likely to experience a subsequent firearm injury compared with those whose ED visit was for a fall, in some parts of the United States.
ExpandThe risks of myocardial infarction (MI), ischemic stroke, and hemorrhagic stroke are increased for patients with high or low average systolic blood pressure (BP). The risks are greater at very low systolic BP than at very high systolic BP.
ExpandAt 24 months post-cessation, 56% of semaglutide, 52% of liraglutide, and 55% of tirzepatide patients kept the weight off or lost additional weight.
ExpandThe proportion of primary care encounters with low-dose aspirin on the medication list fell by more than half, from a peak of 7.4% in mid-2018 to 3.2% by the end of 2025, among patients without a history that warrants low-dose aspirin for secondary prevention. The decline was observed across all demographic subgroups. Adults aged 80+ still had the highest prevalence at 5.7%.
ExpandMale patients aged 10 to 15 who had an ED visit for a motor vehicle crash (MVC) were as much as four times as likely to experience a subsequent firearm injury compared with those whose ED visit was for a fall, in some parts of the United States.
ExpandThe risks of myocardial infarction (MI), ischemic stroke, and hemorrhagic stroke are increased for patients with high or low average systolic blood pressure (BP). The risks are greater at very low systolic BP than at very high systolic BP.
ExpandAt 24 months post-cessation, 56% of semaglutide, 52% of liraglutide, and 55% of tirzepatide patients kept the weight off or lost additional weight.
